Please login to the form below

Not currently logged in
Email:
Password:

COVAX

This page shows the latest COVAX news and features for those working in and with pharma, biotech and healthcare.

China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine

China’s Sinopharm given WHO emergency use listing for COVID-19 vaccine

It is also a prerequisite to supplying vaccines to the international vaccines-sharing facility COVAX. ... We urge the manufacturer to participate in the COVAX Facility and contribute to the goal of more equitable vaccine distribution,” she added.

Latest news

More from news
Approximately 14 fully matching, plus 18 partially matching documents found.

Latest from PMHub

  • Is the world ready for a COVID-19 vaccine?

    One of the ways the world is looking to mitigate this is through the COVAX initiative, which is co-led by the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Alliance ... COVAX is a multinational collaborative platform that is

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....